Drugs / Ametop
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01864213 | May → Oct 2013 | — | University of British Columbia | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT03022240 Background | Jan 2017 → Sep 2019 | — | University of Calgary | Completed | No outcome recorded |
| — | NCT03749915 Comparator | Nov 2018 → Dec 2019 | — | University of British Columbia | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ametop | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03022240 ↗ |
| Route | Topical | “receive Ametop local anesthetic to the dorsum of both hands” NCT03022240 ↗ |